Provision of Assay Kits for SCID & SMA In-Service Evaluations - EONIS-Q Revvity
NHS England · Awarded
- Buyer
- NHS England
- Status
- Awarded
- Country
- United Kingdom
- Region
- EU - Western Europe
- Sector
- Manufacturing
- Reference
- UK-CFA-ocds-b5fd17-63bc49a4-6875-44ee-bcf1-d9ea348f4445
- Published
- 2026-03-12
- Deadline
- 2026-03-12
Tender summary
EONIS-Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 4 Screening laboratories, with the addition of the ISE for Spinal Muscular Atrophy (SMA).
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access